Načítá se...
Defining success in clinical trials of diabetic foot wounds: the Los Angeles DFCon consensus
Regulatory requirements for new products should be guided by clinical trials that protect the public by a thorough evaluation of safety and efficacy, while not creating unnecessary barriers to their development and ultimate approval. While healing a wound is the ultimate goal of treating an individu...
Uloženo v:
| Vydáno v: | Int Wound J |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Publishing Ltd
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7951718/ https://ncbi.nlm.nih.gov/pubmed/19538193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-481X.2009.00598.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|